...
首页> 外文期刊>Osteoarthritis and cartilage >Analysis of ADAMTS4 and MT4-MMP indicates that both are involved in aggrecanolysis in interleukin-1-treated bovine cartilage.
【24h】

Analysis of ADAMTS4 and MT4-MMP indicates that both are involved in aggrecanolysis in interleukin-1-treated bovine cartilage.

机译:对ADAMTS4和MT4-MMP的分析表明,两者都参与了白介素1处理的牛软骨的聚集蛋白水解作用。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: To investigate the mechanism of aggrecanolysis in interleukin-1 (IL-1)-treated cartilage tissue by examining the time course of aggrecan cleavages and the tissue and medium content of membrane type 4-matrix metalloproteinases (MT4-MMP) and a disintegrin and metalloproteinase with thrombospondin type I motifs (ADAMTS)4. METHODS: Articular cartilage explants were harvested from newborn bovine femoropatellar groove. The effects of IL-1 treatment with or without aggrecanase blockade were investigated by Western analysis of aggrecan fragment generation, ADAMTS4 species (p68 and p53), and MT4-MMP, as well as by realtime PCR (polymerase chain reaction) for ADAMTS4 and 5. Aggrecanase was blocked with mannosamine (ManN), an inhibitor of glycosylphosphatidylinositol anchor synthesis, and esculetin (EST), an inhibitor of MMP-1, MMP-3, and MMP-13 gene expression. RESULTS: IL-1 treatment caused a major increase in MT4-MMP abundance in the tissue and medium. ADAMTS4 (p68) was abundant in fresh cartilage and this was retained in the tissue in untreated cartilage. IL-1 treatment for 6 days caused a marked loss of p68 from the cartilage and the appearance of p53 in the medium. Addition of either 1.35 mM ManN or 31-500 microM EST blocked IL-1-mediated aggrecanolysis and this was accompanied by nearly complete inhibition of the MT4-MMP increase, the p68 loss and the formation of p53. IL-1 treatment increased mRNA abundance for ADAMTS4 ( approximately 3-fold) and ADAMTS5 ( approximately 10-fold) but this was not accompanied by a marked change in enzyme protein abundance. CONCLUSION: These studies support a central role for MT4-MMP in IL-1-induced cartilage aggrecanolysis and are consistent with the identification of p68 as the aggrecanase that cleaves within the CS2 domain, and of p53 as the aggrecanase that generates G1-NITEGE. Since the induction by IL-1 was not accompanied by marked changes in total ADAMTS4 protein, but rather in partial conversion of p68 to p53 and release of both from the tissue, we conclude that aggrecanolysis in this model system results from MT4-MMP-mediated processing of a resident pool of ADAMTS4 and release of the p68 and p53 from their normal association with the cell surface.
机译:目的:研究白细胞介素1(IL-1)处理的软骨组织中软骨聚集蛋白水解的机制,研究其聚集时间,膜型4-基质金属蛋白酶(MT4-MMP)和整合素的组织和培养基含量以及具有I型血小板反应蛋白(ADAMTS)的金属蛋白酶4。方法:从新生的牛股骨groove沟收集关节软骨外植体。通过蛋白聚糖片段生成,ADAMTS4种类(p68和p53)和MT4-MMP的Western分析,以及针对ADAMTS4和5的实时PCR(聚合酶链反应),研究了具有或没有蛋白聚糖酶阻断作用的IL-1的作用。 Aggrecanase被甘露糖胺(ManN)(一种糖基磷脂酰肌醇锚定合成的抑制剂)和esculetin(EST)(一种MMP-1,MMP-3和MMP-13基因表达的抑制剂)阻断。结果:IL-1治疗导致组织和培养基中MT4-MMP的丰度大大增加。 ADAMTS4(p68)在新鲜软骨中含量很高,并且保留在未经处理的软骨组织中。 IL-1治疗6天导致软骨中p68明显丢失,并在培养基中出现p53。加入1.35 mM ManN或31-500 microM EST可以阻断IL-1介导的聚集蛋白水解作用,并伴有MT4-MMP升高,p68缺失和p53形成的几乎完全抑制。 IL-1处理增加了ADAMTS4(约3倍)和ADAMTS5(约10倍)的mRNA丰度,但这并未伴随酶蛋白丰度的显着变化。结论:这些研究支持MT4-MMP在IL-1诱导的软骨聚集蛋白水解中的核心作用,并且与鉴定p68为在CS2结构域内裂解的聚集蛋白聚糖酶,以及鉴定p53为产生G1-NITEGE的聚集蛋白聚糖酶一致。由于IL-1的诱导并未伴随着总ADAMTS4蛋白的显着变化,而是伴随着p68向p53的部分转化以及两者从组织中的释放,我们得出结论,该模型系统中的聚集蛋白水解作用是MT4-MMP介导的处理ADAMTS4的驻留池,并从其与细胞表面的正常结合中释放出p68和p53。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号